Sharenet Sites
Sectors
Scanner
To view the PDF file, sign up for a MySharenet subscription.
Back to SYGH SENS 

SYGNIA ITRIX (RF) PROPRIETARY LIMITED - Index Constituent Change - SYGH

Release Date: 03/08/2023 11:10
Code(s): SYGH     PDF:  
Wrap Text
Index Constituent Change - SYGH

SYGNIA ITRIX COLLECTIVE INVESTMENT SCHEME
Sygnia Itrix Solactive Healthcare 150 ETF
JSE Code: SYGH
ISIN: ZAE000300521


A portfolio in the Sygnia Itrix Collective Investment Scheme in
Securities, registered as such in terms of the Collective Investment
Schemes Control Act, 45 of 2002.

INDEX CONSTITUENT CHANGE - SYGH

In terms of section 19.28 of the JSE Limited Listings Requirements,
notice is hereby given to investors of the above ETF securities that
the following changes in the constituents of the underlying index in
the table below is effective from 03 August 2023.
.

The following constituents have been added to SYGH:
                                              
               Share Name                     Previous     New 
 ISIN                                         Weight       Weight
 CH1216478797 DSM FIRMENICH AG                0.00%        0.36121%

US46116X1019  INTRA-CELLULAR THERAPIES INC    0.00%        0.07740%


The following constituents have been removed from SYGH:
                                             
                  Share Name                  Previous     New Weight
 ISIN                                         Weight
US00857U1079     AGILON HEALTH ORD            0.05628%     0.00%

JE00BYSS4X48         NOVOCURE LTD             0.04254%     0.00%

US34965K1079         FORTREA HOLDINGS INC     0.03621%     0.00%


The above gave affect to changes in the index constituent weights.
The portfolio composition file can be viewed at www.sygnia.co.za/etfs/etf-and-etn-fund-range.

03 August 2023

Manager
Sygnia Itrix (RF) Pty Limited


JSE Sponsors
Vunani Sponsors

Date: 03-08-2023 11:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.